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Abstract
Background: Detection of Streptococcus pneumoniae C-polysaccharide in urine is a useful rapid diagnostic test for
pneumococcal infections in adults. In young children, high rates of false positive results have been documented
due to detection of concurrent nasopharyngeal pneumococcal carriage. The relationship between pneumococcal
carriage and urinary antigen detection in adults from developing countries with high pneumococcal carriage
prevalence has not been well established.
Methods: We nested an evaluation of the BinaxNOW S. pneumoniae test within a longitudinal mother-infant
pneumococcal carriage study in Karen refugees on the Thailand-Myanmar border. Paired urine and nasopharyngeal
swab specimens were collected from 98 asymptomatic women at a routine study follow-up visit. The urine
specimens were analyzed with the BinaxNOW test and the nasopharyngeal swabs were semi-quantitatively
cultured to identify pneumococcal colonization.
Results: 24/98 (25%) women were colonized by S. pneumoniae but only three (3%) had a positive BinaxNOW urine
test. The sensitivity of the BinaxNOW test for detection of pneumococcal colonization was 4.2% (95% CI: 0.1 -
21.1%) with a specificity of 97.3% (95% CI: 90.6 - 99.7%). Pneumococcal colonization was not associated with
having a positive BinaxNOW test (odds ratio 1.6; 95% CI: 0.0 - 12.7; p = 0.7).
Conclusions: Significant numbers of false positive results are unlikely to be encountered when using the
BinaxNOW test to diagnose pneumococcal infection in adults from countries with moderate to high rates of
pneumococcal colonization.
Background
Streptococcus pneumoniae is a leading bacterial cause of
pneumonia globally [1]. Identifying pneumococcus as
the etiological agent in pneumonia cases is difficult
since unequivocal confirmation requires isolation of the
organism from a sterile site. However, only ~10% of
pneumonias are bacteremic and few sites are equipped
to obtain lung tissue from pneumonia patients [2,3].
Detection of C-polysaccharide in urine (the BinaxNOW
S. pneumoniae test (Inverness Medical, USA [now
marketed by Alere Inc, USA])) has been demonstrated
to be a useful rapid confirmatory test for pneumococcal
infection in adults, with sensitivity of 74% and specificity
of 94% in a recent systematic review [4]. Unfortunately
the test has poor specificity in children due to detection
of pneumococcal nasopharyngeal colonization: 22 - 67%
of healthy children colonized with S. pneumoniae, from
various countries, have been found to have a positive
BinaxNOW test [5-9]. The effect of nasopharyngeal
colonization on BinaxNOW test performance in adults
has not been widely reported. Studies on the diagnostic
utility of the BinaxNOW test in adults are dominated by
work from high income countries, where pneumococcal
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carriage rates are relatively low, e.g. 8% in the UK [10].
A single study has included a formal assessment of the
influence of concurrent pneumococcal colonization on
the BinaxNOW result: 12% of Spanish HIV-positive
patients in the study control group were colonized with
S. pneumoniae but none had a positive urinary antigen
test [11]. Adult pneumococcal carriage rates in lower
income countries are often much higher than in devel-
oped countries. We have recently demonstrated pneu-
mococcal carriage in 19-27% of young mothers in a
Karen refugee population [12]. If this high rate of colo-
nization translates to the presence of antigen in the
urine it may limit the diagnostic utility of the Binax-
NOW test in certain populations.
In this study we sought to determine whether, in an
area with a moderate to high pneumococcal carriage
rate in young adults, the BinaxNOW S. pneumoniae
urinary antigen test detected asymptomatic pneumococ-
cal nasopharyngeal colonization which would limit its
utility as a diagnostic test for pneumococcal infection.
Methods
The evaluation was nested within a longitudinal pneu-
mococcal carriage study conducted in Maela, a densely
populated camp for Burmese refugees mainly of Karen
ethnicity, 500 km northwest of Bangkok, Thailand [12].
Monthly nasopharyngeal swabs (NPS) were collected
from 234 infants and their mothers from birth until 24
months of age. NPS were collected into STGG transport
medium (prepared in-house) and processed according to
the WHO pneumococcal carriage detection protocol
[13].
Between February and April 2010, mothers were asked
to provide a urine specimen at a scheduled NPS visit.
Women were excluded from participating if they had
been treated for pneumonia in the preceding three
months or had any symptoms of respiratory infection
(fever, earache, coryza, cough, or chest pain) in the pre-
ceding six weeks. Urine specimens were collected into
sterile containers (Sterilin, UK) and stored at 2-8°C until
analysis.
BinaxNOW S. pneumoniae urinary antigen testing was
undertaken on the day of specimen collection, following
the manufacturer’s instructions. Nasopharyngeal swabs
were frozen at -80°C for up to seven weeks prior to cul-
ture. Briefly, the NPS in STGG were fully thawed and
10 μl was cultured on Columbia CNA agar with 5%
sheep blood (bioMerieux, France). Plates were incubated
overnight at 36°C in 5% CO2. S. pneumoniae was identi-
fied by colonial morphology and optochin susceptibility
(zone diameter ≥14 mm) with confirmation by bile solu-
bility when the optochin zone diameter was 7-13 mm.
Colonization density was assessed by estimating the
number of pneumococcal colonies in each of the four
agar plate quadrants: 1+ (growth in quadrant 1 [inocula-
tion area/primary streak] but <10 colonies in quadrant
2), 2+ (>10 colonies in quadrant 2 but <10 colonies in
quadrant 3), 3+ (>10 colonies in quadrant 3 but <10
cols in quadrant 4), or 4+ (>10 colonies in quadrant 4).
Dense colonization was defined as 2+ or more growth
of S. pneumoniae on the primary culture plate. Labora-
tory personnel processing the NPS were unaware of the
urinary antigen results.
Data were entered into a Microsoft Access 2003 data-
base (Microsoft, USA) and systematically checked for
errors. Statistical analysis was carried out in STATA
10.1 (StataCorp, USA): participant’s ages were described
by the median and range since non-normally distributed;
sensitivity and specificity were calculated using the
“diagt” module [14]. Two-tailed p-values of <0.05 and
odds ratios with 95% confidence intervals not spanning
1.0 were considered significant.
Written consent was gained from all participants prior
to enrollment in the study. Ethical approval was granted
by the Ethics Committee of The Faculty of Tropical
Medicine, Mahidol University, Thailand (MUTM 2009-
306) and the Oxford Tropical Research Ethics Commit-
tee, Oxford University, UK (031-06).
Results
One hundred urine specimens were collected: 98 speci-
mens were accompanied by a NPS and these urine-NPS
pairs are considered further. The median participant age
was 25 years (range: 15 - 40).
Three of the ninety eight (3%) urine specimens were
positive by the BinaxNOW test. From the NPS cultures,
24/98 (25%) of women were colonized by S. pneumoniae
at the time of urine collection, including 3/24 women
(13%) who were densely colonized. The sensitivity of the
BinaxNOW test for detection of pneumococcal coloni-
zation was 4.2% (95% CI: 0.1 - 21.1%) with a specificity
of 97.3% (95% CI: 90.6 - 99.7%) (Table 1). Nasopharyn-
geal pneumococcal colonization was not associated with
a positive BinaxNOW test (odds ratio 1.6; 95% CI: 0.0 -
12.7; p = 0.7).
Five colonized women were carrying non-typeable
(unencapsulated) pneumococci, and therefore would not
be expected to develop a positive BinaxNOW test. The
remaining 19 colonized women carried typeable pneu-
mococci (Table 2). The single positive BinaxNOW test
was from a woman colonized by a serotype 5 pneumo-
coccus. Excluding the five women with NT colonization
did not alter the overall results: the sensitivity of the
BinaxNOW test for detection of typeable pneumococcal
colonization was 5.3% (95% CI: 0.1 - 26%), the specificity
was 97.5% (95%CI: 91.2 - 99.7%), and carriage of a
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typeable pneumococcus was not associated with a posi-
tive BinaxNOW test (odds ratio 2.1; 95% CI: 0.0 -
17.5%; p = 0.5).
Discussion
We found that, despite a colonization rate of 25%, only 3%
of healthy adult women had a positive pneumococcal urin-
ary antigen test. This 3% (95% CI: 0 - 9%) false positive
rate is similar to that found in the systematic review and
prospective study of Boulware and colleagues, who
reported an overall specificity of 94% (95% CI: 93-95%)
for adult pneumonia diagnosis and a 2% false positive rate
(1/63) in their non-pneumonia controls (17 HIV positive,
and 46 HIV negative) [4]. Interestingly women who had a
positive urine antigen result did not have significantly
higher odds of being colonized by S. pneumoniae than
those with a negative test, but the sample size is small.
Only one of the women with a positive urinary antigen
test had evidence of pneumococcal nasopharyngeal coloni-
zation. The other two women gave no history of recent
symptoms of, or treatment for, a respiratory infection. It is
possible that they may have had a pneumococcal infection
several months prior to testing or had recently cleared
pneumococcus from the nasopharynx, since detection of
pneumococcal urinary antigen is possible at least six
months after pneumonia diagnosis in a small number of
cases [15].
Compared with the results from studies of young chil-
dren, it is unclear why, with a carriage rate of 12% in the
evaluation of BinaxNOW in Spanish HIV-positive adults,
no urine specimens were positive for pneumococcal anti-
gen [11]. There may be differences in how polysaccharides
are handled by the immune system in infants compared to
adults or there may be issues related to colonization den-
sity in adults compared to infants that explain the differ-
ences. In our carriage study the overall pneumococcal
carriage prevalence was 76% in infants and 24% in
mothers. In the infants, dense pneumococcal colonization
was observed in a significantly higher proportion of infant
culture-positive swabs than mother swabs (47% vs 25%, p
< 0.0001) (unpublished data). This may indicate that pneu-
mococcal colonization density plays a role in the high false
positive rate for the BinaxNOW test in young children,
although in previous studies of children alone have not
been able to confirm this [6,9]. A prospective study of
urinary antigen detection in infant and adult pneumococ-
cal carriers from the same population may clarify this
potential association.
The main limitation of our study was the relatively small
sample size: we may have missed a small association
between pneumococcal colonization (particularly if this is
related to colonization density) and a positive BinaxNOW
test as a result of the small numbers of positive urinary
antigen tests in our participants. Further studies, either a
larger study in our population or in a setting with an even
higher prevalence of adult pneumococcal colonization, are
warranted to confirm our findings.
Conclusions
This study provides reassurance that significant numbers
of false positive results are unlikely to be encountered
when using the BinaxNOW test to diagnose pneumococ-
cal infection in adults from countries with moderate-high
rates of pneumococcal colonization. It provides indirect
evidence that test performance may be similar in low
income countries to that reported from high income
country studies. Further studies from areas with even
higher adult pneumococcal colonization rates, such as
Africa, should be considered. Although these results are
Table 2 Serotypes of carried pneumococci
Serotype Number of isolates
3 1
5 2
6B 1
15A 2
15B 1
17F 1
18F 1
19F 3
19A 2
22F 1
23F 1
28F 1
35C 2
Non-typeable 5
Total 24
Table 1 BinaxNOW S.pneumoniae urinary antigen test and nasopharyngeal swab culture results
NPS culture Total
S. pneumoniae
isolated
S. pneumoniae
not isolated
BinaxNOW urinary antigen Positive 1 2 3
Negative 23 72 95
Total 24 74 98
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encouraging, a considerable reduction in the cost per test
would be required to facilitate inclusion of the Binax-
NOW test in adult pneumonia diagnostic algorithms in
resource-poor settings.
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